Transplant Pathology

Primary Contact

CEO and Transplant Pathology Practice Leader - Donald R. Howard, M.D., Ph.D.

Donald R. Howard, M.D., Ph.D.

Chairman of the Board and CEO

As Chairman and CEO, Dr. Howard leads CellNetix' best-in-class, highly sub-specialized pathology group and laboratories. He has authored numerous publications related to the imunobiology of malignant diseases, particularly breast cancer and lymphomas, and is a regular speaker at national pathology and laboratory conferences. Dr. Howard serves on the editorial advisory board of Washington G2 Reports.

Full Bio

Why CellNetix?

  • Three board certified pathologists with expertise in Transplant Pathology
  • 94% of our biopsies are resulted the same day or the next day
  • All interpretations are called to the referring clinician
  • 24/7 priority access to your local pathologists
  • Reports convey information clearly, concisely and correctly

 

  • Intra-operative consultations with patients’ primary physician and surgeon ensure multidisciplinary care for transplant patients
  • State-of-the-art Information Technology systems with EMR interface capabilities
  • Full service billing department for direct billing of patient insurance, as well as payment plans for cash-paying patients
  • Customizable test requisitions

CellNetix Pathologists with sub-specialty expertise in Transplant Pathology play a crucial role in the diagnosis and management of patients who have received renal, liver, and pancreatic transplants. They process and interpret biopsied material from transplanted organs, as well as biopsies from the native tissue of patients being considered for, or having undergone transplantation. Dr. Don Howard, Chairman of the Board of CellNetix Pathology & Laboratories, leads our Transplant Pathology sub-specialty. CellNetix follows the Banff classification of renal transplant rejection, the most reproducible and widely accepted in the world.

Our Strengths

CellNetix Pathologists can perform immunofluorescence studies on kidney biopsies as well as a variety of immunohistologic and selected molecular studies. Our state-of-the-art bar-coding system has been shown to reduce common histologic slide identification errors by 95% and overall case identification errors by 62%.

  • Three board certified pathologists with expertise in Transplant Pathology
  • 94% of our biopsies are resulted the same day or the next day
  • All interpretations are called to the referring clinician
  • 24/7 priority access to your local pathologists
  • Reports convey information clearly, concisely and correctly
  • Intra-operative consultations with patients’ primary physician and surgeon ensure multidisciplinary care for transplant patients
  • State-of-the-art Information Technology systems with EMR interface capabilities
  • Full service billing department for direct billing of patient insurance, as well as payment plans for cash-paying patients
  • Customizable test requisitions

Our Transplant Pathologists are available to provide their expertise for questions, evaluations and second opinions on all cases pertaining to their specialty.

Types of Testing We Do
  • Immunofluorescence (full panel evaluation for immunoglobulins and complement, C4d)
  • Immunohistochemistry (B-K virus, etc.)
Types of Conditions and Diseases We Test for:
  • Renal Transplant rejection
  • Kidney Disease – primary and secondary
  • Etiology of renal Failure

References

http://cybernephrology.ualberta.ca/Banff/2009/publications.htm